We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

By LabMedica International staff writers
Posted on 14 Mar 2024

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics. More...

Traditionally, exosomes are isolated through ultrasound centrifugation, a process that requires eight hours or more, requires large sample volumes, and often harms the integrity of these delicate structures. Alternative methods also present challenges, including low purity and yield. Now, researchers have devised a diagnostic technique that employs sound waves to spin a single water droplet at speeds reaching 6,000 revolutions per minute, thereby facilitating the separation of tiny biological particles for exosome-based diagnostics.

This novel approach involves a lightweight disk atop the spinning droplet and featuring etched channels that incorporate star-shaped nanoparticles designed for the label-free identification of exosomes. This method surpasses traditional techniques in efficiency, requiring less time and smaller sample volumes, and minimizes damage to the exosomes. It represents a significant advancement from the expensive equipment currently used for exosome isolation, paving the way for point-of-care applications, including precision bioassays and cancer diagnostics.

Developed by mechanical engineers at Duke University (Durham, NC, USA), the technology utilizes a droplet of water placed within a polydimethylsiloxane ring—a silicone material frequently used in microfluidics—to confine the water’s boundaries and keeps it in place. Sound wave generators positioned on either side of the device emit surface acoustic waves that cause the droplet to spin rapidly. A disc with channels etched on its surface is placed on top of the droplet. As the droplet spins, exosomes are driven toward the ends of the channels, separating them from smaller proteins and contaminants.

To detect the presence of specific biomarkers, the researchers used a technological approach that tethers DNA probes dubbed “Inverse Molecular Sentinels” to the points of star-shaped gold nanoparticles. These tethers naturally want to curl up, but are held straight by a segment of DNA that is tailored to bind to the target microRNA being tested for. When that microRNA comes by on its exosome carrier, it sticks to and removes the DNA, allowing the tether to curl and bring the label molecule in close contact with the nanostar. When exposed to a laser, that label molecule emits a very weak Raman signal. However, the shape and composition of the nanostars amplifies the Raman signals several million-fold and make them easier to detect.

“Our technology can discriminate between cancer and control groups with 95.8% sensitivity and 100% selectivity,” said Tony Jun Huang, the William Bevan Distinguished Professor of Mechanical Engineering and Materials Science at Duke. “Its potential is enormous in fundamental biological research and the early diagnosis and health monitoring of cancers, neurodegenerative and other diseases.”

Related Links:
Duke University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.